达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002030 达安基因

已收盘 12-10 15:00:00

{"stockData":{"symbol":"002030","market":"SZ","secType":"STK","nameCN":"达安基因","latestPrice":6.25,"timestamp":1765350237000,"preClose":6.29,"halted":0,"volume":12281644,"delay":0,"changeRate":-0.0064,"floatShares":1403000000,"shares":1403000000,"eps":-0.4019,"marketStatus":"已收盘","change":-0.04,"latestTime":"12-10 15:00:00","open":6.29,"high":6.31,"low":6.21,"amount":76652800,"amplitude":0.0159,"askPrice":6.25,"askSize":936,"bidPrice":6.24,"bidSize":1858,"shortable":0,"etf":0,"ttmEps":-0.4019,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765416600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.29,"symbolType":"stock","openAndCloseTimeList":[[1765330200000,1765337400000],[1765342800000,1765350000000]],"highLimit":6.92,"lowLimit":5.66,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1403446032,"isCdr":false,"pbRate":1.14,"roa":"--","roe":"--","epsLYR":-0.66,"committee":0.18092,"marketValue":8772000000,"turnoverRate":0.0088,"status":1,"floatMarketCap":8772000000},"requestUrl":"/m/hq/s/002030","defaultTab":"news","newsList":[{"id":"2590311634","title":"达安基因：公司目前暂无相关计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2590311634","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590311634?lang=zh_cn&edition=full","pubTime":"2025-12-09 17:12","pubTimestamp":1765271530,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)12月09日在投资者关系平台上答复投资者关心的问题。投资者提问：当前证监会鼓励上市公司并购，目前公司持有安杰思15%的股份，安杰思每年有近3亿的净利润，如果与之并购，使之财务报表合并对公司将产生积极的效果，请问公司有没有这一方面的考虑？谢谢！达安基因回复：投资者您好，感谢您对达安基因的关注和建议。公司目前暂无相关计划。谢谢！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251209/31853498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0188","BK0159","BK0168","BK0046","002030","BK0028","BK0122","BK0042","BK0239"],"gpt_icon":0},{"id":"2588003937","title":"达安基因(002030)11月28日股东户数13.5万户，较上期减少2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588003937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588003937?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:43","pubTimestamp":1764668612,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2025年11月28日公司股东户数为13.5万户，较10月31日减少4000.0户，减幅为2.88%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至11月28日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年10月31日至2025年11月28日，达安基因区间涨幅为0.77%，在此期间股东户数减少4000.0户，减幅为2.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200026426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0159","BK0046","BK0028","BK0042","BK0239","BK0168","BK0188","BK0122"],"gpt_icon":0},{"id":"1192428920","title":"意大利埃尼公司将尼日利亚深水区OML 118区块股份提升至15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192428920","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192428920?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:18","pubTimestamp":1764058734,"startTime":"0","endTime":"0","summary":"11月25日 - 埃尼公司宣布，从TotalEnergies EP Nigeria Limited收购了额外2.5%的OML 118生产分享合同（PSC）股份，行使其优先购买权。此次交易已获得必要的监管审批，使其在OML 118 PSC的股份从12.5%增加至15%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","BK0122","BK0168","BK0159","BK0042","BK0028","BK0188","002030","BK0239"],"gpt_icon":0},{"id":"2585118725","title":"达安基因：截至2025年10月31日股东总户数约为13万9千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585118725","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585118725?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:27","pubTimestamp":1763713636,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至2025年11月20日，公司的股东人数是多少？谢谢。达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2025年10月31日，公司股东总户数约为13万9千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100020190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0159","BK0239","BK0188","BK0042","BK0168","002030","BK0122"],"gpt_icon":0},{"id":"2584237636","title":"达安基因最新公告：间接控股股东拟变更为广药集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2584237636","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584237636?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:51","pubTimestamp":1763383874,"startTime":"0","endTime":"0","summary":"若本次股权转让和本次协议转让实施完成，广药集团将合计控制公司26.63%股份，进而成为公司的间接控股股东。本次交易若成功实施，不会导致公司控股股东及实际控制人发生变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700033592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0239","BK0168","BK0122","BK0188","BK0159","BK0028","BK0042","BK0046"],"gpt_icon":0},{"id":"2583902580","title":"达安基因：截至2025年10月31日股东总户数约为13万9千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2583902580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583902580?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:54","pubTimestamp":1762995256,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好:请问截止11月10日公司股东数量，谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2025年10月31日，公司股东总户数约为13万9千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300008146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0159","BK0046","BK0239","BK0028","BK0042","BK0188","BK0122","BK0168"],"gpt_icon":0},{"id":"2582828917","title":"达安基因：开发有甲型乙型流感病毒检测试剂产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2582828917","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582828917?lang=zh_cn&edition=full","pubTime":"2025-11-10 15:54","pubTimestamp":1762761268,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)11月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司有没有检测日本最新流感病毒的产品达安基因回复：投资者您好，感谢您对达安基因的关注。公司开发有针对甲型、乙型流感病毒的检测试剂产品，可以适配甲、乙流常规分型的病毒检测需求。公司会持续跟踪流感病毒变异情况，以获取最新检测需求动态。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000017125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0159","BK0239","BK0188","BK0042","BK0168","002030","BK0122"],"gpt_icon":0},{"id":"2580913783","title":"达安基因：截至2025年10月31日股东总户数约为13万9千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580913783","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580913783?lang=zh_cn&edition=full","pubTime":"2025-11-04 16:51","pubTimestamp":1762246267,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：您好：请问10月31日股东人数是多少谢谢！达安基因回复：投资者您好，感谢您对达安基因的关注。截至2025年10月31日，公司股东总户数约为13万9千户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400025925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0188","BK0159","BK0239","BK0122","002030","BK0042","BK0028","BK0046"],"gpt_icon":0},{"id":"2579546583","title":"达安基因最新公告：取得一个医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2579546583","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579546583?lang=zh_cn&edition=full","pubTime":"2025-10-31 19:20","pubTimestamp":1761909627,"startTime":"0","endTime":"0","summary":"达安基因公告称，公司近日取得国家药品监督管理局颁发的医疗器械注册证一个，具体为全自动核酸检测分析仪，注册证编号：国械注准20253222122。该医疗器械注册证的取得丰富了公司的产品组合，拓宽了公司产品的应用领域。目前，上述产品尚处于市场开发阶段，市场需求存在不确定性，请广大投资者注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100043708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK1100","BK0028","BK1574","BK0188","BK0042","BK0122","BK0159","BK1222","BK0239","09997","09996","159883","002030","BK1583","BK0168"],"gpt_icon":0},{"id":"2579148529","title":"图解达安基因三季报：第三季度单季净利润同比增长139.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579148529","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579148529?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:20","pubTimestamp":1761823204,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因2025年三季报显示，前三季度公司主营收入5.04亿元，同比下降14.81%；归母净利润-1.42亿元，同比上升71.85%；扣非净利润-3.25亿元，同比上升24.99%；其中2025年第三季度，公司单季度主营收入1.65亿元，同比下降13.5%；单季度归母净利润4065.64万元，同比上升139.28%；单季度扣非净利润-6016.58万元，同比上升76.32%；负债率12.09%，投资收益-498.76万元，财务费用-2960.96万元，毛利率32.67%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000039832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030"],"gpt_icon":0},{"id":"2579619290","title":"达安基因(002030.SZ)发布前三季度业绩，归母净亏损1.42亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579619290","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579619290?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:47","pubTimestamp":1761814058,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达安基因(002030.SZ)发布2025年三季度报告，前三季度，公司实现营业收入5.04亿元，同比下降14.81%。归属于上市公司股东净亏损1.42亿元。归属于上市公司股东的扣除非经常性损益净亏损3.25亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"达安基因(002030.SZ)发布前三季度业绩，归母净亏损1.42亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0159","BK0122","BK0028","002030","BK0168","BK0046","BK0042","BK0188"],"gpt_icon":0},{"id":"2578615788","title":"达安基因：截至2025年9月30日股东总户数约为14万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2578615788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578615788?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:03","pubTimestamp":1761555785,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)10月27日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止10月20号，公司的股东人数是多少？谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2025年9月30日，公司股东总户数约为14万户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700022411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","BK0159","BK0168","BK0046","BK0028","BK0042","002030","BK0188"],"gpt_icon":0},{"id":"2577235457","title":"达安基因(002030)9月30日股东户数14万户，较上期减少4.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577235457","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577235457?lang=zh_cn&edition=full","pubTime":"2025-10-22 17:10","pubTimestamp":1761124216,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2025年9月30日公司股东户数为14.0万户，较8月29日减少6000.0户，减幅为4.11%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2025年8月29日至2025年9月30日，达安基因区间跌幅为5.78%，在此期间股东户数减少6000.0户，减幅为4.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200026720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0159","BK0168","BK0188","BK0239","BK0046","BK0028","002030","BK0122","BK0042"],"gpt_icon":0},{"id":"2575237594","title":"达安基因：截至2025年9月30日股东总户数约为14万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2575237594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575237594?lang=zh_cn&edition=full","pubTime":"2025-10-14 08:45","pubTimestamp":1760402713,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)10月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止至2025年10月10日收盘公司股东人数为多少，谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2025年9月30日，公司股东总户数约为14万户。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400032250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0046","BK0042","BK0168","BK0122","BK0159","BK0028","002030","BK0239"],"gpt_icon":0},{"id":"2575179604","title":"股市必读：达安基因(002030)股东户数14万户，较上期减少4.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575179604","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575179604?lang=zh_cn&edition=full","pubTime":"2025-10-13 04:12","pubTimestamp":1760299936,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，达安基因报收于6.38元，下跌0.62%，换手率0.92%，成交量12.98万手，成交额8293.04万元。当日关注点来自交易信息汇总：10月10日主力资金净流出463.82万元，散户资金净流入670.09万元。股本股东变化股东户数变动截至2025年9月30日，达安基因股东户数为14.0万户，较8月29日减少6000.0户，减幅为4.11%。户均持股数量由上期的9613.0股上升至1.0万股，户均持股市值为6.38万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300001444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0042","BK0168","BK0159","BK0046","002030","BK0188","BK0028","BK0239"],"gpt_icon":0},{"id":"2574124175","title":"达安基因(002030)9月30日股东户数14万户，较上期减少4.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574124175","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574124175?lang=zh_cn&edition=full","pubTime":"2025-10-10 17:53","pubTimestamp":1760090017,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2025年9月30日公司股东户数为14.0万户，较8月29日减少6000.0户，减幅为4.11%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2025年8月29日至2025年9月30日，达安基因区间跌幅为5.78%，在此期间股东户数减少6000.0户，减幅为4.11%。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202510/10/20251010570224.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202510/10/20251010570224.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251010/31696927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0168","BK0188","BK0159","BK0239","BK0122","002030","BK0042","BK0028","BK0046"],"gpt_icon":0},{"id":"2571826562","title":"股市必读：达安基因（002030）9月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2571826562","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571826562?lang=zh_cn&edition=full","pubTime":"2025-09-29 01:49","pubTimestamp":1759081753,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，达安基因报收于6.28元，上涨1.29%，换手率1.45%，成交量20.34万手，成交额1.28亿元。公司仅提供每月月末股东人数，截至2025年8月29日，公司股东总户数约为14万6千户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900000757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0122","BK0046","BK0028","BK0239","002030","BK0159","BK0042","BK0168"],"gpt_icon":0},{"id":"2570078346","title":"达安基因(002030.SZ)：基孔肯雅病毒核酸检测试剂盒(荧光PCR法)取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2570078346","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570078346?lang=zh_cn&edition=full","pubTime":"2025-09-26 11:52","pubTimestamp":1758858766,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达安基因(002030.SZ)发布公告，近日，公司取得国家药品监督管理局颁发的医疗器械注册证一个，该医疗器械名称为：基孔肯雅病毒核酸检测试剂盒(荧光PCR法)，注册证编号：国械注准20253401955。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK0122","BK0028","BK0046","BK0239","BK1583","159883","BK0188","09997","BK0042","BK1222","BK1574","002030","BK0168","PCR","BK0159","BK1100"],"gpt_icon":0},{"id":"2569522710","title":"股市必读：达安基因（002030）9月19日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2569522710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569522710?lang=zh_cn&edition=full","pubTime":"2025-09-22 02:16","pubTimestamp":1758478574,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，达安基因报收于6.28元，下跌0.79%，换手率1.03%，成交量14.43万手，成交额9063.0万元。来自机构调研要点：截至2025年6月30日，华南以外地区营收占比达55%，公司将持续拓展县域及海外市场。未来如有相关的并购计划，公司将严格遵守法律法规及时履行信息披露义务。投资者您好，感谢您对达安基因的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200000755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","002030","BK0188","BK0168","BK0159","BK0042","BK0239","BK0122"],"gpt_icon":0},{"id":"2565502227","title":"达安基因(002030.SZ)：人类免疫缺陷病毒1型(HIV-1)DNA检测试剂盒取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2565502227","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565502227?lang=zh_cn&edition=full","pubTime":"2025-09-08 17:31","pubTimestamp":1757323867,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达安基因(002030.SZ)发布公告，近日，公司取得国家药品监督管理局颁发的医疗器械注册证一个，具体为：人类免疫缺陷病毒1型(HIV-1)DNA检测试剂盒(PCR 荧光探针法)，注册证编号：国械注准20253401805。有效期自批准之日起至2030 年9月4日。预期用途：本产品用于体外定性检测人全血样本中的人类免疫缺陷病毒1型脱氧核糖核酸(HIV-1DNA)(仅M组)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK0168","BK0122","09997","BK0046","DNA","BK0159","BK1574","BK1583","BK0239","09996","BK1100","BK4109","BK4121","BK4139","BK0188","BK0042","BK1222","002030","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765403976894,"stockEarnings":[{"period":"1week","weight":-0.031},{"period":"1month","weight":-0.0686},{"period":"3month","weight":-0.0414},{"period":"6month","weight":0.0575},{"period":"1year","weight":-0.0443},{"period":"ytd","weight":0.1004}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0294},{"period":"3month","weight":0.0065},{"period":"6month","weight":0.155},{"period":"1year","weight":0.1396},{"period":"ytd","weight":0.1637}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州达安基因股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"135000人(较上一季度减少2.88%)","perCapita":"40963股","listingDate":"2004-08-09","address":"广东省广州市黄埔区高新技术开发区科学城香山路19号","registeredCapital":"140344万元","survey":"　　广州达安基因股份有限公司的主营业务是以分子诊断技术为主导的，集临床检验试剂、仪器和配套耗材的研发、生产、销售。公司的主要产品是荧光定量PCR系列产品（临床）、化学发光系列、时间分辨系列产品、酶联免疫系列产品、胶体金系列产品、生化系列产品、质谱系列产品、POCT系列产品、仪器与软件类产品、荧光分析系列产品、免疫层析系列产品、微柱凝胶系列产品、荧光原位杂交产品、样本采集系列产品、核酸提取系列产品、检测服务产品、科研服务产品。","listedPrice":7.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达安基因(002030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达安基因,002030,达安基因股票,达安基因股票老虎,达安基因股票老虎国际,达安基因行情,达安基因股票行情,达安基因股价,达安基因股市,达安基因股票价格,达安基因股票交易,达安基因股票购买,达安基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达安基因(002030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}